Grant: Discovery Grants Program - Individual
Université de Montréal
$50,000.00
Accelerated evolution of enzyme activity to determine functional and structural tolerance
EF 2017-18
Résumé
The industrial application of enzymes is gaining in importance world-wide, as a result of their high catalytic power and the potential for modification by enzyme engineering. Our goal is to increase the scope and efficiency of enzyme engineering, by determining the tolerance of specific enzymes to intensive, targeted mutational efforts. Different enzymes appear to show different tolerance to active-site mutations. Here, we propose to study two different, unrelated enzyme systems. Following extensive modification using powerful molecular biological methodologies, we will characterize the functional variants to establish their tolerance to intensive, targeted mutations. The first system under study consists of clinically-relevant ß-lactamases which hydrolyze antibiotics such as penicillins. It is urgent to better define the molecular nature of such rapidly evolving antibiotic resistance. Artificially engineered, catalytically active chimeras of ß-lactamases will be characterized by kinetics, circular dichroism and protein NMR. These laboratory-generated ß-lactamases are an original and highly effective system for observing tolerance to high mutation load. Insight into the structure-function relationship of these artificially evolved yet functional enzymes will provide insight into the rapid development of drug resistance, while establishing a greater knowledge base for effective enzyme engineering. The second system is R67 dihydrofolate reductase, an enzyme that provides bacterial resistance to the antibiotic trimethoprim. We will identify binding scaffolds for inhibitor development to this recently evolved drug target, toward discovery of new antibiotics. In parallel, we will modify the active site of this enzyme to develop new biocatalysts for reduction of synthetically-useful prochiral imines and ketones. Comparison of the mutational tolerance and the resulting structure-function effects of these systems will contribute to advancing our capacity in enzyme engineering. Along with the development of new biocatalysts, this knowledge will serve an important industrial need.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
227853-2010
Name nom
Pelletier, Joelle
Department département
Chimie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2010
Award amount
50000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5404
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Enzymes
Research subject fr
Enzymes
Partie
8
Nb partie
8
Application title
Accelerated evolution of enzyme activity to determine functional and structural tolerance
Keyword
NSERC
Application summary
The industrial application of enzymes is gaining in importance world-wide, as a result of their high catalytic power and the potential for modification by enzyme engineering. Our goal is to increase the scope and efficiency of enzyme engineering, by determining the tolerance of specific enzymes to intensive, targeted mutational efforts. Different enzymes appear to show different tolerance to active-site mutations. Here, we propose to study two different, unrelated enzyme systems. Following extensive modification using powerful molecular biological methodologies, we will characterize the functional variants to establish their tolerance to intensive, targeted mutations. The first system under study consists of clinically-relevant ß-lactamases which hydrolyze antibiotics such as penicillins. It is urgent to better define the molecular nature of such rapidly evolving antibiotic resistance. Artificially engineered, catalytically active chimeras of ß-lactamases will be characterized by kinetics, circular dichroism and protein NMR. These laboratory-generated ß-lactamases are an original and highly effective system for observing tolerance to high mutation load. Insight into the structure-function relationship of these artificially evolved yet functional enzymes will provide insight into the rapid development of drug resistance, while establishing a greater knowledge base for effective enzyme engineering. The second system is R67 dihydrofolate reductase, an enzyme that provides bacterial resistance to the antibiotic trimethoprim. We will identify binding scaffolds for inhibitor development to this recently evolved drug target, toward discovery of new antibiotics. In parallel, we will modify the active site of this enzyme to develop new biocatalysts for reduction of synthetically-useful prochiral imines and ketones. Comparison of the mutational tolerance and the resulting structure-function effects of these systems will contribute to advancing our capacity in enzyme engineering. Along with the development of new biocatalysts, this knowledge will serve an important industrial need.